Charles H. Sherwood
2017
In 2017, Charles H. Sherwood earned a total compensation of $4.2M as Chief Executive Officer at Anika Therapeutics, a 20% increase compared to previous year.
Compensation breakdown
| Bonus | $466,981 |
|---|---|
| Option Awards | $2,960,954 |
| Salary | $622,641 |
| Other | $187,037 |
| Total | $4,237,612 |
Sherwood received $3M in option awards, accounting for 70% of the total pay in 2017.
Sherwood also received $467K in bonus, $622.6K in salary and $187K in other compensation.
Rankings
In 2017, Charles H. Sherwood's compensation ranked 2,378th out of 14,666 executives tracked by ExecPay. In other words, Sherwood earned more than 83.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,378 out of 14,666 | 84th |
Division Manufacturing | 835 out of 5,772 | 86th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 109 out of 859 | 87th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 57 out of 531 | 89th |
Industry Surgical and Medical Instruments and Apparatus | 37 out of 336 | 89th |
Source: SEC filing on April 17, 2018.
Sherwood's colleagues
We found six more compensation records of executives who worked with Charles H. Sherwood at Anika Therapeutics in 2017.
2017
Joseph Darling
Anika Therapeutics
President
2017
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
2017
Edward Ahn
Anika Therapeutics
Chief Technology and Strategy Officer
2017
Ed Ahn
Anika Therapeutics
Chief Technology and Strategy Officer
2017
Richard Hague
Anika Therapeutics
Chief Commerical Officer
2017
Thomas Finnerty
Anika Therapeutics